Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultratrace Iobenguane I 131 in Malignant Pheochromocytoma/Paraganglioma
NCT00458952Phase 2Completed
- Sponsor
- Molecular Insights Pharmaceuticals
- Start
- Apr 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Iobenguane I-131 in pheochromocytoma, Paraganglioma (PGL), sponsored by Molecular Insights Pharmaceuticals. Started Apr 2007; status: completed.
02
Drugs
Iobenguane I-131
03
Conditions
pheochromocytomaParaganglioma (PGL)
Beyond the preview
Go deeper on NCT00458952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00458952.